Literature DB >> 16981192

Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis.

Nicola J Cooper1, Paul C Lambert, Keith R Abrams, Alexander J Sutton.   

Abstract

This article focuses on the modelling and prediction of costs due to disease accrued over time, to inform the planning of future services and budgets. It is well documented that the modelling of cost data is often problematic due to the distribution of such data; for example, strongly right skewed with a significant percentage of zero-cost observations. An additional problem associated with modelling costs over time is that cost observations measured on the same individual at different time points will usually be correlated. In this study we compare the performance of four different multilevel/hierarchical models (which allow for both the within-subject and between-subject variability) for analysing healthcare costs in a cohort of individuals with early inflammatory polyarthritis (IP) who were followed-up annually over a 5-year time period from 1990/1991. The hierarchical models fitted included linear regression models and two-part models with log-transformed costs, and two-part model with gamma regression and a log link. The cohort was split into a learning sample, to fit the different models, and a test sample to assess the predictive ability of these models. To obtain predicted costs on the original cost scale (rather than the log-cost scale) two different retransformation factors were applied. All analyses were carried out using Bayesian Markov chain Monte Carlo (MCMC) simulation methods. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 16981192     DOI: 10.1002/hec.1141

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  14 in total

1.  Survival analysis with time-dependent covariates subject to missing data or measurement error: Multiple Imputation for Joint Modeling (MIJM).

Authors:  Margarita Moreno-Betancur; John B Carlin; Samuel L Brilleman; Stephanie K Tanamas; Anna Peeters; Rory Wolfe
Journal:  Biostatistics       Date:  2018-10-01       Impact factor: 5.899

2.  Modeling Semicontinuous Longitudinal Expenditures: A Practical Guide.

Authors:  Valerie A Smith; Matthew L Maciejewski; Maren K Olsen
Journal:  Health Serv Res       Date:  2018-01-08       Impact factor: 3.402

3.  A zero-augmented generalized gamma regression calibration to adjust for covariate measurement error: A case of an episodically consumed dietary intake.

Authors:  George O Agogo
Journal:  Biom J       Date:  2016-10-05       Impact factor: 2.207

4.  Modeling a bivariate residential-workplace neighborhood effect when estimating the effect of proximity to fast-food establishments on body mass index.

Authors:  A James O'Malley; Peter James; Todd A MacKenzie; Jinyoung Byun; S V Subramanian; Jason P Block
Journal:  Stat Med       Date:  2018-11-20       Impact factor: 2.373

5.  Results from using a new dyadic-dependence model to analyze sociocentric physician networks.

Authors:  Sudeshna Paul; Nancy L Keating; Bruce E Landon; A James O'Malley
Journal:  Soc Sci Med       Date:  2014-07-15       Impact factor: 4.634

6.  Using Retrospective Sampling to Estimate Models of Relationship Status in Large Longitudinal Social Networks.

Authors:  A James O'Malley; Sudeshna Paul
Journal:  Comput Stat Data Anal       Date:  2015-02-01       Impact factor: 1.681

7.  A Bayesian model for repeated measures zero-inflated count data with application to outpatient psychiatric service use.

Authors:  Brian H Neelon; A James O'Malley; Sharon-Lise T Normand
Journal:  Stat Modelling       Date:  2010-12       Impact factor: 2.039

8.  A flexible two-part random effects model for correlated medical costs.

Authors:  Lei Liu; Robert L Strawderman; Mark E Cowen; Ya-Chen T Shih
Journal:  J Health Econ       Date:  2009-11-22       Impact factor: 3.883

9.  Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial-Based Cost-Effectiveness Data.

Authors:  Felix Achana; Daniel Gallacher; Raymond Oppong; Sungwook Kim; Stavros Petrou; James Mason; Michael Crowther
Journal:  Med Decis Making       Date:  2021-04-05       Impact factor: 2.583

Review 10.  Review of statistical methods for analysing healthcare resources and costs.

Authors:  Borislava Mihaylova; Andrew Briggs; Anthony O'Hagan; Simon G Thompson
Journal:  Health Econ       Date:  2010-08-27       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.